NASDAQ:NBRV
Nabriva Therapeutics plc
- Stock
Last Close
1.41
31/07 20:00
Market Cap
4.55M
Beta: 1.55
Volume Today
706.54K
Avg: 12.53K
PE Ratio
−0.08
PFCF: −0.17
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | -306.12K - | -306.12K 0% | 341K - | 3.25M 853.81% | 10.17M 212.56% | 12.09M 18.95% | |||||
average payables | 437.83K - | 1.65M 276.28% | 2.75M 66.64% | 3.84M 40.00% | 4.22M 9.80% | 3.99M 5.49% | 3.78M 5.20% | 3.63M 3.98% | 4.90M 35.01% | ||
average receivables | 1.53M - | 3.28M 114.00% | 5.19M 58.46% | 5.48M 5.55% | 5.39M 1.73% | 4.06M 24.67% | 3.33M 18.02% | 8.33M 150.41% | 9.75M 17.00% | ||
book value per share | -213.57 - | -337.03 57.80% | 2.57K 862.40% | 899.24 65.00% | 687.79 23.51% | 337.77 50.89% | 139.06 58.83% | 64.49 53.63% | 30.77 52.29% | 1.23 96.01% | |
capex per share | -0.30 - | -0.76 149.51% | -3.87 409.77% | -7.02 81.19% | -9.83 40.06% | -1.13 88.54% | -0.21 81.76% | -0.22 7.01% | -0.01 93.44% | -0.08 445.67% | |
capex to depreciation | -0.17 - | -0.54 224.13% | -1.09 99.81% | -2.59 138.09% | -2.72 4.92% | -0.45 83.46% | -0.08 82.36% | -0.14 73.95% | -0.04 71.52% | -0.97 2,377.55% | |
capex to operating cash flow | 0.01 - | 0.01 22.66% | 0.01 4.00% | 0.01 62.18% | 0.02 38.35% | 0.00 81.38% | 0.00 73.05% | 0.00 86.70% | 0.00 73.50% | 0.01 1,269.24% | |
capex to revenue | -1.95 - | -0.04 - | -0.01 77.65% | -0.04 401.15% | -0.00 97.67% | -0.01 544.00% | |||||
cash per share | 41.76 - | 19.78 52.64% | 2.64K 13,264.62% | 976.38 63.06% | 728.11 25.43% | 503.13 30.90% | 290.41 42.28% | 80.53 72.27% | 27.49 65.86% | 4.63 83.17% | |
days of inventory on hand | 3.56K - | 2.77K 21.98% | 402.78 85.48% | 123.57 69.32% | |||||||
days payables outstanding | 24.37K - | 1.38K 94.35% | 121.37 91.18% | 69.36 42.85% | |||||||
days sales outstanding | 20.97K - | 301.60 - | 129.27 57.14% | 498.18 285.39% | 171.01 65.67% | 68.99 59.65% | |||||
debt to assets | 2.23 - | 5.56 149.35% | 0.00 99.98% | 0.00 - | 0.21 8,766.41% | 0.37 70.67% | 0.13 63.93% | 0.10 24.94% | 0.16 65.61% | ||
debt to equity | -0.71 - | -0.73 3.58% | 0.00 100.20% | 0.00 - | 0.35 12,125.03% | 0.84 141.88% | 0.23 72.10% | 0.15 35.46% | 1.59 953.37% | ||
dividend yield | |||||||||||
earnings yield | 0.43 - | -0.45 205.11% | -3.08 582.43% | -4.29 39.10% | -0.42 90.28% | -1.55 271.31% | -0.85 45.40% | -2.24 164.52% | -1.90 14.79% | -11.28 492.30% | |
enterprise value | 47.88M - | 60.68M 26.74% | -26.42M 143.54% | -19.98M 24.38% | 91.85M 559.78% | -4.12M 104.49% | 46.43M 1,225.97% | -2.55M 105.49% | -13.67M 436.62% | -2.12M 84.46% | |
enterprise value over ebitda | 1.71 - | -6.22 464.73% | 1.53 124.63% | 0.37 76.05% | -1.27 444.97% | 0.04 102.85% | -0.59 1,725.68% | 0.04 106.68% | 0.28 617.14% | 0.04 86.21% | |
ev to operating cash flow | -9.25 - | -5.76 37.70% | 1.21 121.08% | 0.41 66.65% | -1.32 427.00% | 0.06 104.28% | -0.65 1,238.98% | 0.04 105.53% | 0.23 542.71% | 0.06 74.79% | |
ev to sales | -314.51 - | -0.63 - | 5.99 1,044.60% | -0.89 114.84% | -0.50 43.53% | -0.06 88.14% | |||||
free cash flow per share | -47.88 - | -97.53 103.71% | -517.74 430.83% | -581.10 12.24% | -591.01 1.71% | -359.05 39.25% | -242.43 32.48% | -139.05 42.64% | -34.36 75.29% | -13.77 59.94% | |
free cash flow yield | -0.14 - | -0.29 103.71% | -2.15 630.57% | -3.90 81.16% | -0.40 89.86% | -0.98 148.83% | -0.73 25.32% | -2.30 212.85% | -2.29 0.15% | -7.28 217.39% | |
graham net net | -230.18 - | -349.61 51.89% | 2.50K 814.79% | 838.88 66.43% | 647.29 22.84% | 317.29 50.98% | 120.47 62.03% | 42.66 64.59% | 21.30 50.07% | -2.30 110.79% | |
graham number | 826.79 - | 1.06K 28.79% | 6.55K 514.84% | 3.60K 45.08% | 3.11K 13.63% | 2.07K 33.28% | 934.09 54.92% | 442.98 52.58% | 140.51 68.28% | 24.27 82.73% | |
income quality | -0.33 - | 0.65 293.53% | 0.69 7.09% | 0.90 29.64% | 0.93 3.80% | 0.63 32.07% | 0.87 37.10% | 1.03 18.18% | 1.20 17.32% | 0.64 46.70% | |
intangibles to total assets | 0.00 - | 0.00 32.83% | 0.00 98.90% | 0.00 10,336.39% | 0.00 37.97% | 0.00 50.59% | 0.00 8.94% | 0.00 41.59% | 0.00 72.01% | 0.00 75.35% | |
interest coverage | 4.02 - | -1.40 134.75% | -1.64 17.55% | -733.96 44,558.07% | -1.72K 133.74% | -859.96 49.87% | -21.81 97.46% | -38.11 74.72% | 53.86 241.32% | -73.31 236.12% | |
interest debt per share | 201.73 - | 310.60 53.96% | 348.46 12.19% | 0.87 99.75% | 2.30 164.00% | 117.39 4,993.39% | 128.53 9.49% | 18.42 85.67% | 4.11 77.67% | 2.21 46.32% | |
inventory turnover | 0.10 - | 0.13 28.16% | 0.91 588.87% | 2.95 225.96% | |||||||
invested capital | -0.71 - | -0.73 3.58% | 0.00 100.20% | 0.00 - | 0.35 12,125.03% | 0.84 141.88% | 0.23 72.10% | 0.15 35.46% | 1.59 953.37% | ||
market cap | 36.02M - | 36.02M 0% | 10.18M 71.73% | 12.80M 25.73% | 178.39M 1,293.53% | 74.16M 58.43% | 97.94M 32.07% | 31.09M 68.26% | 25.96M 16.48% | 5.07M 80.48% | |
net current asset value | -24.17M - | -37.46M 54.99% | 107.31M 386.43% | 74.64M 30.45% | 80.14M 7.38% | 66.97M 16.44% | 38.33M 42.76% | 31.92M 16.73% | 52.71M 65.13% | 2.63M 95.01% | |
net debt to ebitda | 0.42 - | -2.53 698.39% | 2.12 183.96% | 0.60 71.63% | 1.19 98.09% | 0.69 42.49% | 0.65 4.99% | 0.52 20.46% | 0.82 57.47% | 0.13 83.90% | |
net income per share | 142.25 - | -149.52 205.11% | -741.38 395.84% | -638.90 13.82% | -623.15 2.46% | -564.91 9.35% | -278.86 50.64% | -135.23 51.50% | -28.52 78.91% | -21.32 25.23% | |
operating cash flow per share | -47.57 - | -96.77 103.42% | -513.87 430.99% | -574.08 11.72% | -581.18 1.24% | -357.92 38.42% | -242.23 32.32% | -138.83 42.69% | -34.35 75.26% | -13.69 60.15% | |
payables turnover | 0.01 - | 0.27 1,670.02% | 3.01 1,034.22% | 5.26 74.99% | |||||||
receivables turnover | 0.02 - | 1.21 - | 2.82 133.32% | 0.73 74.05% | 2.13 191.32% | 5.29 147.86% | |||||
research and ddevelopement to revenue | 270.59 - | 12.66 - | 3.41 73.07% | 5.27 54.67% | 0.46 91.20% | 0.40 13.83% | |||||
return on tangible assets | 2.11 - | -3.38 260.15% | -0.27 92.16% | -0.59 122.35% | -0.78 31.75% | -1.04 33.76% | -0.88 15.39% | -1.19 35.27% | -0.61 48.65% | -1.80 194.47% | |
revenue per share | 1.98 - | 31.99 - | 26.11 18.40% | 5.57 78.65% | 15.70 181.58% | 13.30 15.27% | |||||
roe | -0.67 - | 0.44 166.61% | -0.29 165.04% | -0.71 146.24% | -0.91 27.52% | -1.67 84.59% | -2.01 19.90% | -2.10 4.58% | -0.93 55.80% | -17.37 1,773.52% | |
roic | -3.05 - | 1.00 132.61% | -0.22 121.80% | -0.70 224.29% | -0.91 29.70% | -1.24 35.72% | -1.05 15.23% | -1.62 54.39% | -0.80 50.75% | -6.18 673.91% | |
sales general and administrative to revenue | 93.07 - | 6.42 - | |||||||||
shareholders equity per share | -213.57 - | -337.03 57.80% | 2.57K 862.40% | 899.24 65.00% | 687.79 23.51% | 337.77 50.89% | 139.06 58.83% | 64.49 53.63% | 30.77 52.29% | 1.23 96.01% | |
stock based compensation to revenue | -7.20 - | 0.79 - | 1.26 58.67% | 1.82 44.84% | 0.12 93.36% | 0.06 54.39% | |||||
tangible asset value | -23.27M - | -36.69M 57.67% | 108.78M 396.51% | 76.99M 29.23% | 81.90M 6.38% | 68.53M 16.32% | 41.18M 39.91% | 33.05M 19.74% | 53.32M 61.30% | 3.29M 93.83% | |
tangible book value per share | -213.83 - | -337.03 57.62% | 2.57K 862.38% | 896.09 65.12% | 686.34 23.41% | 337.29 50.86% | 138.76 58.86% | 64.33 53.64% | 30.75 52.20% | 1.23 96.01% | |
working capital | -14.29M - | -31.08M 117.53% | 107.39M 445.53% | 74.74M 30.40% | 80.58M 7.81% | 90.95M 12.87% | 74.53M 18.05% | 38.69M 48.08% | 57.92M 49.70% | 3.50M 93.96% |
All numbers in USD (except ratios and percentages)